Peroxisome Proliferator-Activated Receptor δ Agonist, HPP593, Prevents Renal Necrosis under Chronic Ischemia

• Larisa V. Fedorova ,

  * E-mail: Larisa.fedorova@utoledo.edu

  Affiliation Department of Medicine, The University of Toledo School of Medicine, Toledo, Ohio, United States of America

  ⨯
• Komal Sodhi,

  Current address: Department of Surgery and Pharmacology, Marshall University Joan C Edwards School of Medicine, Huntington, West Virginia, United States of America

  Affiliation Department of Physiology and Pharmacology, The University of Toledo School of Medicine, Toledo, Ohio, United States of America

  ⨯
• Cara Gatto-Weis,

  Affiliation Department of Pathology, The University of Toledo School of Medicine, Toledo, Ohio, United States of America

  ⨯
• Nitin Puri,

  Affiliation Department of Physiology and Pharmacology, The University of Toledo School of Medicine, Toledo, Ohio, United States of America

  ⨯
• Terry D. Hinds Jr,

  Affiliation Department of Physiology and Pharmacology, The University of Toledo School of Medicine, Toledo, Ohio, United States of America

  ⨯
• Joseph I. Shapiro,

  Current address: Department of Surgery and Pharmacology, Marshall University Joan C Edwards School of Medicine, Huntington, West Virginia, United States of America

  Affiliation Department of Medicine, The University of Toledo School of Medicine, Toledo, Ohio, United States of America

  ⨯
• Deepak Malhotra

  Affiliation Department of Medicine, The University of Toledo School of Medicine, Toledo, Ohio, United States of America

  ⨯